Spero Therapeutics nabs Allergan executive — 3 insights

Spero Therapeutics appointed Ian Critchley, PhD, head of clinical microbiology.

Here's what you should know.

1. Dr. Critchley will oversee Spero's preclinical and clinical microbiology efforts.

2. He has more than 30 years of experience in anti-infective drug discovery.

3. Dr. Critchley most recently was Allergan's vice president of clinical microbiology. At Allergan, he managed preclinical and clinical microbiology studies on anti-infective compounds.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast